Skip to main content
. 2006 Sep;59(9):972–977. doi: 10.1136/jcp.2005.031252

Table 2 Immunophenotypic profile of the immune cells in the normal breast, benign proliferative breast disease, ductal carcinoma in situ and infiltrating ductal carcinoma in both parenchyma and stroma.

CD3+ CD20+ CD68+ Granzyme B+
Parenchyma Stroma Parenchyma Stroma Parenchyma Stroma Parenchyma Stroma
Normal 2.8 (1.0) 1.4 (0.6) 3.2 (1.0) 0.7 (0.3) 1.3 (0.7) 1.0 (0.6) 0.5 (0.3) 0.0 (0.0)
Benign proliferative breast disease 81.5 (14.0) 4.2 (1.2) 26.4 (7.8) 3.0 (1.2) 3.8 (1.2) 4.0 (0.6) 2.3 (1.4) 0.5 (0.3)
Ductal carcinoma in situ 84.0 (14.9) 46.6 (16.7) 33.6 (7.9) 13.3 (6.7) 12.7 (3.7) 16.7 (1.7) 8.5 (6.9) 0.7 (0.3)
Infiltrating ductal carcinoma 103.7 (3.9) 77.0 (5.0) 39.1 (4.7) 16.7 (8.8) 22.1 (4.1) 21.7 (4.4) 16.3 (4.9) 0.7 (0.3)

Values are mean (standard error of mean).